维普期刊资源整合服务平台（V6.5）

74篇 您的检索式：作者名="Rasenack"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B显示文摘	Edward J. Gane Gilbert Deray Yun-Fan Liaw Seng Gee Lim Ching-Lung Lai Jens Rasenack Yuming Wang George Papatheodoridis Adrian Di Bisceglie Maria Buti Didier Samuel Alkaz Uddin Sophie Bosset Aldo Trylesinski	2014	Gastroenterology2014，，1：	2
2	Preparation of Microcrystals by in Situ Micronization 显示文摘	RASENACK N STECKEL H MuLLER B W	2004	Powder Technology2004，，：	1
3	Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process 显示文摘	Rasenack N Steckel H Mailer B W	2003	J Pharm Sci2003，92，1：	1
4	Peginterferon alfa2a in patients with cheonic hepatitis C显示文摘	Zeuzem S Feiman SV Rasenack J	2000	N Engl J Med2000，343，：	1
5	Dissolution Rate Enhancement by In-situ Micronization of Poorly Water Soluble Drugs 显示文摘	Rasenack N Mtlller B W	2002	Pharm Res2002，19，：	1
6	Ibuprofen crystal with optimized properties显示文摘	RASENACK N MüLLER BW	2002	Int J Pharm2002，245，12：	1
7	Baseline characteristics and early on-treatment response predict the outcomes of 2<ce:hsp sp='0.25'/>years of telbivudine treatment of chronic hepatitis B显示文摘	Stefan Zeuzem Edward Gane Yun-Fan Liaw Seng G. Lim Adrian DiBisceglie Maria Buti Anuchit Chutaputti Jens Rasenack Jinlin Hou Christopher O’Brien Tuan T. Nguyen Jidong Jia Thierry Poynard Bruce Belanger Weibin Bao Nikolai V. Naoumov	2009	Journal of Hepatology2009，，1：	1
8	Dissolution Rate Enhancement by In-situ Micronization of Poorly Water Soluble Drugs 显示文摘	Rasenack N Muller B W	2002	Pharm Res2002，19，：	1
9	Crystal habit and tableting behavior显示文摘	RASENACK N MüLLER W	2002	Int J Pharm2002，244，12：	1
10	Peginterferon alfa- 2a in patients with chronic hepatitis C 显示文摘	Feinman SV Rasenack J	2000	N Engl J Med2000，343，：	1
11	Peginterferon alfa-2a in patients with chronic hepatitis C 显示文摘	Zeuzem S Feinman SV Rasenack J	2000	N Engl J Med2000，，：	1
12	Preparation of microcrystals by in situ micronization显示文摘	RASENACK N STECKEL H MüLLER BW	2004	Powder Technology2004，，：	1
13	Ca2+/calmodulindependent protein kinase Ⅱ regulates cardiac Na + channels显示文摘	Wagner S Dybkova N Rasenack EC	2006	J Clin Invest2006，116，12：	1
14	显示文摘	Rasenack N Steckel H Muller B W	2004	Powder Technology2004，，：	1
15	In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate 显示文摘	Steckel H Rasenack N Villax P	2003	Int J Pharm2003，258，12：	1
16	Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs显示文摘	Norbert Rasenack Bernd W. Müller	2002	Pharmaceutical Research2002，，12：	1
17	Ca2 +/ealmodnlin- dependent protein kinase I1 regulates cardic Na+ ehannels显示文摘	Wange S Dybkova N Rasenack EC	2006	J Clin Invest2006，116，12：	1
18	Peginterferon alfa-2a in patients with chronic hepatitis C显示文摘	Zeuzem S Feinman SV Rasenack J	2000	New Engl J Med2000，343，：	1
19	Micronization of anti- inflammatory drugs for pulmonary delivery by a controlled crystallization process 显示文摘	Rasenack N Steckel H Miiller BW	2003	J Pharm Sci2003，92，1：	1
20	Micron - size drug particles : common and novelmicronization techniques 显示文摘	Rasenack N Muller BW	2004	Phram Dev Technol2004，9，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示